Instrument Inactif

Autres langues Apyx Medical Corp Nasdaq

Actions

US03837C1062

Temps réel estimé Cboe BZX Autres places de cotation 18:58:38 17/05/2024			Varia. 5j.	Varia. 1 janv.
1,565 ^USD	-74,68%		+14,44%	-4,63%

09/05	Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024
09/05	Apyx Medical Corporation présente ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical	09/05
Apyx: Q1 Earnings Snapshot	09/05
Earnings Flash (APYX) APYX MEDICAL CORPORATION Reports Q1 Revenue $10.2M	09/05
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook	09/05
Apyx Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Apyx Medical Corporation Reaffirms Earnings Guidance for the Full Year Ending December 31, 2024	09/05
Apyx Medical Corporation Announces Board Leadership Transition	09/05
Apyx Medical Corporation Announces Board Leadership Transition	09/05
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	25/04
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS' SUMMIT	12/04
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit	11/04
Archon Capital Management Engages with Apyx Medical Corporation	05/04
Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation	01/04
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS, INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK	22/03
Apyx: Q4 Earnings Snapshot	21/03
Apyx Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook	21/03
Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024	21/03
Apyx Medical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
North American Morning Briefing : Investors -2-	21/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Apyx Medical Corp Nasdaq

Actions

US03837C1062

Autres langues

Filtres